Smartkarma's AI Co-Pilot, Smartkarma

αSK

Smartkarma's AI Co-Pilot

Smartkarma

Smartkarma unites the fragmented investment industry, connecting institutional investors, independent research providers, and corporates within a single network.

Research Reinvented

Equity Bottom-Up

<ul>
  <li>
<a href="https://smartkarma.com/entities/erytech-pharma-sa">Erytech Pharma Sa</a> merged with Pherecydes Pharma in June 2023, rebranding as Phaxiam Therapeutics and shifting its focus to developing bacteriophage therapies to combat antimicrobial resistance.</li>
  <li>Phaxiam was advancing a pipeline of phage therapies targeting severe bacterial infections, with a lead program in a Phase II study for prosthetic joint infections.</li>
  <li>In a critical development, Phaxiam Therapeutics announced in June 2025 that it has entered into judicial liquidation and will be delisted, with no expected reimbursement for shareholders.</li>
</ul><p><em>This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.</em></p>


  
Erytech Pharma Sa merged with Pherecydes Pharma in June 2023, rebranding as Phaxiam Therapeutics and shifting its focus to developing bacteriophage therapies to combat antimicrobial resistance.
  Phaxiam was advancing a pipeline of phage therapies targeting severe bacterial infections, with a lead program in a Phase II study for prosthetic joint infections.
  In a critical development, Phaxiam Therapeutics announced in June 2025 that it has entered into judicial liquidation and will be delisted, with no expected reimbursement for shareholders.
This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.

Primer: Erytech Pharma Sa (ERYP US) - Apr 2026

France

Erytech Pharma S.A. operates as a biopharmaceutical company. The Company discovers and developes therapies for rare forms of cancer and orphan diseases. Erytech Pharma serves customers in France and the United States.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Primer: Erytech Pharma Sa (ERYP US) - Apr 2026

Erytech Pharma Sa merged with Pherecydes Pharma in June 2023, rebranding as Phaxiam Therapeutics and shifting its focus to developing...

αSK